Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis

Cystic Fibrosis Clinical Trial

Official title:

Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04451213
• Other study ID #: 19/MAR/7625
• Status: Completed
• Phase: N/A
• Start date: August 23, 2021
• Est. completion date: December 23, 2022

Study information

• Verified date: August 2023
• Source: Cardiff and Vale University Health Board
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

CF is a complex, inherited illness that can affect many organs of the body. The investigators have found that some patients with CF have reported more problems with memory than would be expected at their age and that patients appear to be using memory strategies to overcome memory loss. The investigators intend to objectively test memory and examine MRI images of the brain of patients with CF.

Description:

Patients with CF have several potential risk factors which may predispose them to memory problems. Because the CF population has historically only been young, this is not something that has been focused on. No research has currently identified whether patients with CF have a much earlier risk of developing cognitive impairment or how CF impacts on the brain. There has not previously been work in this area of CF and the investigators are in a unique position with the Cardiff University Brain Research Imaging Centre (CUBRIC) and its expertise to be able to perform Magnetic Resonance Imagining (MRI) scans and neurocognitive testing on patients with CF for the first time.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: December 23, 2022
• Est. primary completion date: December 23, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years and older

Eligibility

Inclusion Criteria:

• Male or Female, aged greater or equal to 30 years
• A diagnosis of CF
• Primary school education or above
• Able to provide informed consent

Exclusion Criteria:

• Contraindications to MRI as found on the CUBRIC screening form (including presence of indwelling metal devices/clips)
• Existing neurological disease affecting cognition (including stroke and traumatic brain injury)
• Existing diagnosis of dementia documented in medical notes
• Vascular complications of diabetes
• Requiring supplemental oxygen -long term or overnight
• Hepatic failure
• Overt psychiatric disorders
• Past or present alcohol or recreational drug misuse
• Pregnancy
• Current infection Smoker

Related Conditions & MeSH terms

• Cystic Fibrosis
• Fibrosis

Intervention

Diagnostic Test:
• MRI head
MRI head

Locations

Country	Name	City	State
United Kingdom	Cardiff and VAle University Health Board	Cardiff

Sponsors (2)

Lead Sponsor	Collaborator
Cardiff and Vale University Health Board	Cardiff University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Objective memory scores		up to one year
Secondary	MRI head	the investigators will acquire structural and functional MRI data at 3T to explore brain health of CF patients compared to control data. Structural MRI will include T1 and T2 weighted anatomical images for group comparisons of brain morphology (volume, cortical thickness). T1 weighted images will also be used as reference images for all other MRI parameters.	up to one year